Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$518.81 - $607.81 $950,978 - $1.11 Million
-1,833 Reduced 7.33%
23,190 $13.5 Million
Q1 2024

May 15, 2024

BUY
$473.42 - $539.26 $2.04 Million - $2.32 Million
4,300 Added 20.75%
25,023 $13.4 Million
Q4 2023

Feb 14, 2024

SELL
$437.42 - $470.64 $2.23 Million - $2.4 Million
-5,102 Reduced 19.76%
20,723 $9.59 Million
Q3 2023

Nov 14, 2023

BUY
$402.4 - $446.42 $4.42 Million - $4.9 Million
10,975 Added 73.91%
25,825 $11.2 Million
Q2 2023

Aug 14, 2023

BUY
$354.01 - $427.31 $5.26 Million - $6.35 Million
14,850 New
14,850 $6.35 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $82.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Point72 Europe (London) LLP Portfolio

Follow Point72 Europe (London) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Europe (London) LLP with notifications on news.